The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.

The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...

According to the latest data from the Centers for Disease Control, the current bird flu outbreak has caused 67 human cases of ...

Moderna recently received $590 million to help develop vaccines to fight the virus. Their protein-based vaccines have had ...

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...